About DocGo, Inc. 
DocGo, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 37 Schemes (18.67%)
Foreign Institutions
Held by 45 Foreign Institutions (4.72%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
76 Million
(Quarterly Results - Mar 2026)
Net Profit:
-17 Million
Pharmaceuticals & Biotechnology
USD 57 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.28
-69.71%
0.39
Footer loading






